News | January 16, 2021
Bayer gearing up for 2021-2030 decade
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Move strengthens footprint in Western India and expands multi-specialty care network
Focus on preventive, tech-driven healthcare and digital ecosystem reforms under AB PM-JAY and ABDM
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Subscribe To Our Newsletter & Stay Updated
